SIX:ROP
Roche Holding AG · SIX · Healthcare · CHF · FY for 2025
Figures on this page computed 2026-11-08 13:00 UTC
Last close
n/aCHF
Market data
24.1xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- computed
- Computed from the filing for 2025
25.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
20.9%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
22.9%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
0.98Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
2.7%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- computed
Growth is the furthest below its sector's middle: 0.40 against 0.47 on the market's range.
Ten years as a story
lens 9 of 9We hold no filed year for this company, so there is nothing to read.
Nothing is drawn in its place. The other lenses are unaffected.